|
|
4108 Sorrento Valley Boulevard San Diego, CA 92121 USA phone:1-858-875-8000 fax:1-858-535-2035
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.aconlabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Blood Glucose Monitoring, Clinical Chemistry including Urinalysis, and Immunoassay products |
 |
| Management |
| Steven T. Frankel, President |
| |
|
|
| |
|
| Keywords |
| rapid diagnostic, fertility, infectious disease, drug of abuse, tumor marker, pregnancy, InfectiousDisease |
|
|
|
| Description |
|
Inverness Medical Innovations, Inc. will acquire ACON's business. ACON focuses on rapid diagnostic test systems and associated healthcare products. |
 |
| Products / Services |
The seven key groups in ACON'S rapid test product line are: Fertility, Infectious Diseases, Drugs of Abuse, Tumor Markers, Cardiac Markers, Blood Glucose MonitoringNew, UrinalysisNew, and Medical ElectronicsNew. ACON currently sells over 100 diagnostic products for Pregnancy (hCG), Ovulation (LH), Menopause (FSH), HBsAg, HBsAb, HBeAb, HBeAg, HBcAb, HCV, HIV 1/2/O, H pylori, Malaria, Strep A, Chlamydia, Syphilis, Mono, FOB, PSA, AFP, CEA, Troponin I, Myoglobin, CK-MB, Drugs of Abuse, Urine Adulteration, Glucose Monitoring, Urinalysis, Body Temperature Monitoring, and Blood Pressure Monitoring.
|
 |
 |
|
|
|
|
|
|